Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 0

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
ANIXA
BIOSCIENCES, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in
thousands, except share and per share data)

    July
    31, 2025  
    October
    31, 2024 
  
    ASSETS 

    Current
    assets: 

    Cash
    and cash equivalents 
    $1,495  
    $1,271 
  
    Short-term
    investments 
     14,534  
     18,653 
  
    Receivables 
     -  
     173 
  
    Prepaid
    expenses and other current assets 
     1,420  
     1,265 
  
    Total
    current assets 
     17,449  
     21,362 

    Operating
    lease right-of-use asset 
     202  
     229 

    Total
    assets 
    $17,651  
    $21,591 

    LIABILITIES
    AND EQUITY 

    Current
    liabilities: 

    Accounts
    payable 
    $276  
    $525 
  
    Accrued
    expenses 
     1,751  
     1,946 
  
    Operating
    lease liability, current 
     39  
     29 
  
    Total
    current liabilities 
     2,066  
     2,500 

    Operating
    lease liability, non-current 
     174  
     203 
  
    Total
    liabilities 
     2,240  
     2,703 

    Commitments
    and contingencies (Note 10) 
     -   
     -  

    Equity: 

    Shareholders’
    equity: 

    Preferred
    stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding 
     -  
     - 
  
    Series
    A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding 
     -  
     - 
  
     Preferred stock, value  
     -  
     - 

    Common
    stock, par value $.01 per share; 100,000,